Clinic
Klickitat County Public Hospital District No 1
Klickitat County Public Hospital District No 1 was paid $13.12M by Medicaid between Jan 2018 and Dec 2024, across 137 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoKLICKITAT COUNTY PUBLIC HOSPITAL DISTRICT NO 1
GOLDENDALE, WA 98620
GOLDENDALE, WA 98620
33aNPI1386689487assigned 06/20/2006
33bProvider typePhysical Therapy Clinic/Center
28Total paid$13.12M
24GClaims154,780
24DCodes billed137
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Physical Therapy Clinic/Center providers in Washington
Rank by total paid#1 of 53
Median peer was paid$134K
This provider vs. median98×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,425 | $1.43M | |
| 2019 | 23,192 | $1.47M | |
| 2020 | 20,707 | $1.52M | |
| 2021 | 23,125 | $1.92M | |
| 2022 | 23,808 | $2.29M | |
| 2023 | 25,588 | $2.41M | |
| 2024incomplete | 18,935 | $2.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 12,010 | 9,705 | $2.89M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 4,784 | 3,581 | $2.52M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.3% | 2,132 | 1,290 | $956K |
| 80053 | Comprehensive metabolic panel | 4.8% | 12,435 | 10,714 | $627K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.8% | 7,904 | 2,852 | $504K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.7% | 12,383 | 10,387 | $482K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.5% | 4,737 | 4,486 | $329K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.4% | 193 | 169 | $311K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 1,836 | 1,513 | $265K |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 2,346 | 1,706 | $245K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 16,958 | 13,889 | $240K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.8% | 4,863 | 1,793 | $237K |
125 more codes
| 80061 | Lipid panel | 1.7% | 4,110 | $221K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 2,476 | $197K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 1,731 | $186K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 2,183 | $181K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 2,894 | $177K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 1,726 | $151K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 2,336 | $144K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 2,871 | $142K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 1,361 | $141K |
| 80305 | <1% | 2,424 | $117K | |
| 84484 | <1% | 2,571 | $110K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 701 | $108K |
| 82728 | <1% | 1,345 | $101K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 284 | $98K |
| 83690 | <1% | 1,848 | $88K | |
| 81001 | <1% | 4,055 | $86K | |
| 73630 | <1% | 618 | $80K | |
| 83605 | <1% | 1,472 | $70K | |
| 84439 | <1% | 1,106 | $66K | |
| 71045 | Radiologic examination, chest; single view | <1% | 674 | $57K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,612 | $53K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 511 | $46K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 440 | $43K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 860 | $40K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 252 | $39K |
| 85610 | <1% | 2,127 | $38K | |
| 83880 | <1% | 483 | $37K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 312 | $37K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,090 | $37K |
| 87070 | <1% | 962 | $34K | |
| 83735 | <1% | 1,241 | $32K | |
| 87077 | <1% | 971 | $32K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 708 | $27K |
| 85379 | <1% | 437 | $26K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 606 | $25K |
| 97162 | <1% | 237 | $23K | |
| 82607 | <1% | 281 | $21K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,109 | $20K |
| 85730 | <1% | 863 | $20K | |
| 87186 | <1% | 504 | $17K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,871 | $17K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 95 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 477 | $15K |
| 73030 | <1% | 105 | $15K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,429 | $14K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 395 | $14K |
| 85652 | <1% | 463 | $13K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 269 | $13K |
| 85027 | <1% | 457 | $12K | |
| 73130 | <1% | 99 | $11K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 388 | $10K |
| 87400 | <1% | 139 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 79 | $9K |
| 73610 | <1% | 83 | $9K | |
| 87807 | <1% | 71 | $8K | |
| J2704 | Injection, propofol, 10 mg | <1% | 156 | $8K |
| 81003 | <1% | 467 | $8K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 134 | $7K |
| 81025 | <1% | 256 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 30 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 112 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 113 | $7K |
| 82570 | <1% | 276 | $6K | |
| 87430 | <1% | 135 | $6K | |
| 82150 | <1% | 134 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 51 | $6K |
| 82043 | <1% | 139 | $5K | |
| 94760 | <1% | 209 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 127 | $4K |
| A4550 | Surgical trays | <1% | 387 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 88 | $4K |
| G0378 | Hospital observation service, per hour | <1% | 28 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 58 | $3K |
| 87040 | <1% | 79 | $3K | |
| 84703 | <1% | 104 | $3K | |
| 80306 | <1% | 29 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 236 | $3K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 703 | $3K |
| 97161 | <1% | 26 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 14 | $3K |
| 80143 | <1% | 32 | $3K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 186 | $3K |
| 74018 | <1% | 12 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 145 | $2K |
| 87081 | <1% | 26 | $2K | |
| 80179 | <1% | 31 | $2K | |
| 73562 | <1% | 19 | $2K | |
| 86140 | <1% | 78 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 210 | $1K |
| 96376 | <1% | 15 | $1K | |
| 97014 | <1% | 41 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 16 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 15 | $1K |
| 84481 | <1% | 13 | $1K | |
| 86038 | <1% | 16 | $1K | |
| 82746 | <1% | 12 | $998.10 | |
| 97164 | <1% | 29 | $760.32 | |
| 93000 | <1% | 17 | $741.12 | |
| 93041 | <1% | 16 | $598.64 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $526.35 |
| 82948 | <1% | 20 | $466.21 | |
| 85007 | <1% | 22 | $465.60 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 67 | $358.41 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 39 | $350.36 |
| 0002A | <1% | 33 | $344.04 | |
| 81015 | <1% | 18 | $307.23 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 16 | $293.62 |
| 87205 | <1% | 17 | $270.00 | |
| 83540 | <1% | 12 | $238.47 | |
| 86803 | <1% | 12 | $227.85 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 27 | $215.89 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $153.52 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 168 | $143.59 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 45 | $132.10 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $108.30 |
| 0001A | <1% | 40 | $87.59 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 14 | $86.33 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 27 | $75.87 |
| J1800 | Injection, propranolol hcl, up to 1 mg | <1% | 45 | $57.57 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 14 | $53.18 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 429 | $34.98 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 16 | $14.98 |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 91 | $0.00 |
| 80348 | 0% | 19 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 5,138 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHIEBERT, LESLIE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Klickitat County Public Hospital District No 1 | Goldendale, WA | $15.84M |
| Klickitat County Public Hospital District No 1 | Goldendale, WA | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.